The England & Wales Court of Appeal has upheld Mr Justice Arnold's finding that key claims of Warner-Lambert's patent for Lyrica are invalid for insufficiency. The judgment also reiginites the debate over the scope of second medical use patents
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Leaders at the IP firms, which have joined forces with backing from a PE investor, share their vision of building the number one pan-European IP practice
The opinion provides useful guidance when it comes to how courts might consider contributory infringement, DMCA claims, and other issues in AI copyright cases